Ilan Ganot insider trades: Solid Biosciences (SLDB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ilan reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | SLDB | ↓ Sell | 2,658 | $5.82 | $15K | Wife | Feb 18, 2026 (0d) |
| Feb 4, 2026 | SLDB | ↓ Sell | 7,205 | $6.44 | $46K | Wife | Feb 6, 2026 (2d) |
| Jan 28, 2026 | SLDB | ↓ Sell | 191 | $6.59 | $1K | Wife | Jan 30, 2026 (2d) |
| Jan 5, 2026 | SLDB | ↓ Sell | 1,053 | $5.43 | $6K | Wife | Jan 6, 2026 (1d) |
| Nov 10, 2025 | SLDB | ↓ Sell | 3,278 | $4.12 | $14K | Direct | Nov 13, 2025 (3d) |
| Feb 14, 2025 | SLDB | ↓ Sell | 1,711 | $3.96 | $7K | Wife | Feb 18, 2025 (4d) |
| Jan 28, 2025 | SLDB | ↓ Sell | 144 | $3.11 | $448 | Wife | Jan 29, 2025 (1d) |
| Jan 6, 2025 | SLDB | ↓ Sell | 1,056 | $4.31 | $5K | Wife | Jan 7, 2025 (1d) |
| May 2, 2024 | SLDB | ↓ Sell | 462 | $10.33 | $5K | Wife | May 6, 2024 (4d) |
| Jan 29, 2024 | SLDB | ↓ Sell | 139 | $7.99 | $1K | Wife | Jan 30, 2024 (1d) |
| Jan 3, 2024 | SLDB | ↓ Sell | 1,142 | $5.30 | $6K | Wife | Jan 5, 2024 (2d) |
| May 2, 2023 | SLDB | ↓ Sell10b5-1 | 487 | $4.85 | $2K | Wife | Jun 8, 2023 (37d) |
| Jan 27, 2023 | SLDB | ↓ Sell10b5-1 | 1,382 | $7.49 | $10K | Direct | Jan 31, 2023 (4d) |
| Jan 27, 2023 | SLDB | ↓ Sell10b5-1 | 141 | $7.49 | $1K | Wife | Jan 31, 2023 (4d) |
| Feb 10, 2022 | SLDB | ↓ Sell10b5-1 | 463 | $1.12 | $519 | Wife | Mar 8, 2022 (26d) |
| Feb 12, 2021 | SLDB | ↓ Sell | 457 | $7.66 | $4K | Wife | Feb 16, 2021 (4d) |
| Jan 28, 2021 | SLDB | ↓ Sell | 10,713 | $6.14 | $66K | Direct | Jan 29, 2021 (1d) |
| Aug 13, 2020 | SLDB | ↓ Sell | 299 | $2.44 | $730 | Wife | Aug 14, 2020 (1d) |
| Jul 28, 2020 | SLDB | ↓ Sell | 11,124 | $2.42 | $27K | Direct | Jul 29, 2020 (1d) |
| Nov 15, 2018 | SLDB | ↓ Sell10b5-1 | 50,000 | $30.84 | $1.5M | Direct | Nov 19, 2018 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SLDB insiders
Open-market trades in the last 12 months
About Ilan Ganot's insider trades
Ilan Ganot is an insider at Solid Biosciences (SLDB). Since Nov 15, 2018, Ilan has reported no open-market purchases and 20 sales worth $1.8M on SEC Form 4. In the last 12 months: 5 sales ($82K).
5 sales (88% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (21 filings), option exercises (19 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLDB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.